Use of a compound having the formula
Use of a compound having the formula
Use of a compound having the formula
or combinations thereof, for providing a source of butyrate with improved organoleptic properties wherein R1, R2, R3, R4, R5 and R6 are independently a long chain fatty acid having between 16 and 20 carbons for use in promoting immune response and/or preventing and/or treating bacterial and/or viral infections.
The present disclosure provides, in part, compositions comprising mixed allergen powders of one or more nut flours and one or more excipients, methods of producing the compositions, and methods of using the same for the prevention and treatment of nut allergies.
The present invention relates to bone health and in particular to use of a composition comprising a combination of taurine and vitamin B3 for prevention or treatment of bone disorders or maintenance of bone health. The present invention also relates to compositions and methods for enhancing bone quality, bone growth and/or bone strength.
The present invention relates to use of a composition comprising an effective amount of a combination of taurine and vitamin B3 for maintenance of joint health or prevention or treatment of joint disorders in an individual. In particular, the invention relates to a composition comprising an effective amount of a combination of taurine and vitamin B3 for use to prevent or treat cartilage degeneration in an individual.
A beverage composition contains fermented cascara or fermented cascara extract. A further aspect is a method of preparing a beverage composition, the method including steeping cascara in water to form an aqueous cascara extract and steeped cascara; and fermenting the aqueous cascara extract in a presence or absence of the steeped cascara. The fermenting is performed by yeast in an absence of acetic acid bacteria. A still further aspect is the yeast Pichia kluyveri NYSC 5485 (CNCM I-5525).
A process for making a pet food composition uses a red seaweed as a natural gelling agent with enhanced palatability. The compositions can be devoid of commonly used, chemically treated gelling agents such as carrageenan, alginate, agar, and gellan gum.
A23K 10/30 - Produits alimentaires pour animaux à base de matières d’origine végétale, p. ex. de racines, de graines ou de foinProduits alimentaires pour animaux à base de matières d’origine fongique, p. ex. de champignons
A23L 29/238 - Aliments ou produits alimentaires contenant des additifsLeur préparation ou leur traitement contenant des agents gélifiants ou épaississants d'origine végétale à partir de graines, p. ex. gomme de caroube ou gomme de guar
A23L 29/25 - Exsudats, p. ex. gomme arabique, gomme acacia, gomme karaya ou gomme adragante
A23L 29/256 - Aliments ou produits alimentaires contenant des additifsLeur préparation ou leur traitement contenant des agents gélifiants ou épaississants d'origine végétale à base d'algues, p. ex. alginates, agar-agar ou carraghénane
A23L 29/269 - Aliments ou produits alimentaires contenant des additifsLeur préparation ou leur traitement contenant des agents gélifiants ou épaississants d'origine microbienne, p. ex. xanthane ou dextrane
Bifidobacterium longuminfantisinfantis for use in preventing and/or treating constipation and/or improving stool consistency and/or stool frequency in an infant or a young child, wherein the HMO mixture consists of 2'-fucosyllactose (2FL), difucosyllactose (DFL), lacto-N-tetraose (LNT), 6'-sialyllactose (6SL), and 3'- sialyllactose (3SL), and optionally 3-fucosyllactose (3FL) and/or lacto-N-neotetraose (LNnT). The present invention also provides a combination of a human milk oligosaccharide (HMO) mixture and Bifidobacterium longum subsp. infantis, wherein the HMO mixture comprises or consists of 3'-Galactosyllactose (3'GL), 6'-Galactosyllactose (6'GL), 4'-Galactosyllactose (4'GL), 2'-fucosyllactose (2FL), difucosyllactose (DFL), lacto-N-tetraose (LNT), 6'-sialyllactose (6SL), and 3'-sialyllactose (3SL), and optionally 3-fucosyllactose (3FL) and/or lacto-N- neotetraose (LNnT). The present invention further provides a combination of a human milk oligosaccharide (HMO) mixture, milk fat globule membrane (MFGM) and Bifidobacterium longum subsp. infantis, wherein the HMO mixture comprises or consists of 3'- Galactosyllactose (3'GL), 6'-Galactosyllactose (6'GL), 4'-Galactosyllactose (4'GL), 2'- fucosyllactose (2FL), difucosyllactose (DFL), lacto-N-tetraose (LNT), 6'-sialyllactose (6SL), and 3'-sialyllactose (3SL), and optionally 3-fucosyllactose (3FL) and/or lacto-N-neotetraose (LNnT).
The present invention relates to a process and composition for preparing a hydrolyzed coconut product. The process of the present invention comprises the steps of enzymatically hydrolyzing a wet pressed coconut cake and liquefying the wet pressed coconut cake. Advantageously, the subject matter of the present invention allows it, for example, to use side streams of coconut processes i.e., wet pressed coconut cake and coconut water or water to prepare a low fat containing hydrolyzed coconut product.
The invention relates heat treated beverages containing fluid gels comprising particles formed from gellan and divalent cations, particularly calcium. The fluid gel beverage are surprisingly heat stable and maintain suspensive properties after heat treatment including UHT (ultra high temperature) heat treatment.
A23C 9/154 - Préparations à base de laitLait en poudre ou préparations à base de lait en poudre comportant des additifs contenant des substances épaississantes, des œufs ou des préparations à base de céréalesLait gélifié
A23C 9/152 - Préparations à base de laitLait en poudre ou préparations à base de lait en poudre comportant des additifs
A23C 11/10 - Succédanés du lait, p. ex. compositions pour remplacer le lait dans le café au lait contenant au moins un composé d'origine non laitière comme source de matières grasses ou de protéines contenant ou non du lactose mais pas d'autres composés d'origine laitière comme sources de matières grasses, d'hydrates de carbone ou de protéines
A23L 11/60 - Boissons à base de légumineuses, p. ex. boissons à base de lupin
A23L 29/00 - Aliments ou produits alimentaires contenant des additifsLeur préparation ou leur traitement
A23L 29/269 - Aliments ou produits alimentaires contenant des additifsLeur préparation ou leur traitement contenant des agents gélifiants ou épaississants d'origine microbienne, p. ex. xanthane ou dextrane
13.
MIRNAS FROM A BIOLOGICAL SAMPLE AS INDICATORS OF STRESS IN BOVINE
The present invention relates miRNA biomarkers from a biological sample, e.g. exosome-derived microRNA, as indicators of welfare in bovines. In particular, the present invention relates to the identification of heat stress in bovines allowing to propose management actions to improve productive animal welfare at the individual or the herd levels.
The present invention provides a foaming creamer powder comprising proteins, fat, and entrapped gas within the powder, wherein the foaming creamer powder has a volume-weighted average pore wall thickness of from 10 μm to 30 μm. The present invention also provides a process for manufacturing a foaming creamer powder comprising simultaneous or near simultaneous steam and gas injection.
The invention relates to a method for making a food powder with improved stability, in particular decreased hygro-capacity and increased hygro-stability. The method comprises the provision of a liquid food composition, the drying of the liquid food composition and the addition of crystalline mono- and/or di-saccharides to the food powder. In particular, at most 30% of the mono- and/or di-saccharides of the food powder are amorphous and the remainder of mono- and/or di-saccharides of the food powder are crystalline.
A23C 9/18 - Lait sous la forme d'un produit comprimé sec ou semi-solide
A23C 1/05 - Concentration, évaporation ou séchage par pulvérisation dans un courant gazeux combinés avec l'agglomération
A23C 1/16 - Concentration, évaporation ou séchage combinés avec un autre traitement comportant l'emploi d'additifs
A23C 9/142 - Préparations à base de laitLait en poudre ou préparations à base de lait en poudre dans lesquelles la composition chimique du lait est modifiée par des traitements non chimiques par dialyse, osmose inverse ou ultrafiltration
A23C 9/156 - Préparations aromatisées à base de lait
A23C 9/158 - Préparations à base de laitLait en poudre ou préparations à base de lait en poudre comportant des additifs contenant des vitamines ou des antibiotiques
Mineral waters, aerated and carbonated waters, spring
waters, still waters, treated waters, flavored waters and
non-alcoholic fruit-based and/or fruit-flavored beverages;
fruit juices, fruit nectars, lemonades, soda water and other
non-alcoholic beverages, syrups and other non-alcoholic
preparations for making beverages; isotonic beverages;
energy drinks.
21.
REDUCTION OF ASTRINGENCY IN PLANT PROTEIN BASED BEVERAGES
The invention relates to a plant protein based drink comprising oat bran or oat bran extract, wherein said oat bran or oat bran extract comprises between 0.1% to 6% of the total solid content on a dry basis in the plant protein based drink, and wherein at least 15% of the solids on a dry basis contributed by the oat bran or oat bran extract are beta-glucans.
A23L 29/206 - Aliments ou produits alimentaires contenant des additifsLeur préparation ou leur traitement contenant des agents gélifiants ou épaississants d'origine végétale
22.
D-BHB (D-BETA-HYDROXYBUTYRATE) FOR TREATMENT OF LONG CHAIN FATTY ACID OXYDATION DEFICIENCY (LC-FAOD)
The present invention relates to the use of D-beta-hydroxybutyrate (D-BHB) in the treatment or dietary management of a Long-Chain Fatty Acid Oxidation Deficiency (LC-FAOD), for example, in the prevention and/or amelioration of one or more symptoms associated with LC-FOAD. Additionally, the invention provides compositions comprising D-BHB as the active ingredient. These compositions may be formulated as pharmaceutical compositions or nutritional compositions, such as Foods for Special Medical Purposes (FSMPs).
A61K 31/706 - Composés ayant des radicaux saccharide et des hétérocycles ayant l'azote comme hétéro-atome d'un cycle, p. ex. nucléosides, nucléotides contenant des cycles à six chaînons avec l'azote comme hétéro-atome d'un cycle
A61P 3/00 - Médicaments pour le traitement des troubles du métabolisme
The present invention relates to a combination of DHA, ARA, iron, folic acid, Vitamin B12 and phospholipids and to a nutritional composition comprising such a combination for use in improving social-emotional skills and/or in promoting mood, social and joy-related behaviours in an infant, a toddler or a young child. The present invention also relates to a synthetic nutritional composition comprising DHA, ARA, iron, folic acid, Vitamin B12 and phospholipids in specific amounts. The present invention further relates to uses and methods for improving social-emotional skills and/or for promoting mood, social and joy-related behaviours in an infant, a toddler or a young child.
A61K 31/202 - Acides carboxyliques, p. ex. acide valproïque ayant un groupe carboxyle lié à une chaîne acyclique d'au moins sept atomes de carbone, p. ex. acides stéarique, palmitique ou arachidique ayant au moins trois doubles liaisons, p. ex. acide linolénique
A23L 33/00 - Modification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement
A61K 31/519 - PyrimidinesPyrimidines hydrogénées, p. ex. triméthoprime condensées en ortho ou en péri avec des hétérocycles
A61K 31/683 - Diesters d'acide du phosphore avec deux composés hydroxyle, p. ex. phosphatidylinositols
A61K 31/685 - Diesters d'acide du phosphore avec deux composés hydroxyle, p. ex. phosphatidylinositols un des composés hydroxylés ayant des atomes d'azote, p. ex. phosphatidylsérine, lécithine
A61K 31/688 - Diesters d'acide du phosphore avec deux composés hydroxyle, p. ex. phosphatidylinositols les deux composés hydroxylés ayant des atomes d'azote, p. ex. sphingomyélines
A61K 31/714 - Cobalamines, p. ex. cyanocobalamine, vitamine B12
A liquid non-dairy creamer composition contains high oleic oils; micellar casein; emulsifiers including a mixture of mono- and di-glycerides and diacetyl tartaric acid esters of mono- and di-glycerides; and including comprising a mixture of carrageenan, microcrystalline cellulose and carboxymethyl cellulose. A process of preparing theliquid creamer composition includes dissolving the ingredients in hot water under agitation to form a composition; sterilizing the composition using ultra-high temperature (UHT) treatment; homogenizing the composition at total pressure of 135 to 300 bars and a temperature of 65 to 80 °C, before the UHT treatment, after the UHT treatment, or both before and after the UHT treatment; sterilizing the composition at UHT conditions at 136-150 °C for 3-30 seconds to form a beverage base product; cooling the beverage base product to 25°C or below to form the liquid creamer composition; and aseptically filling the liquid creamer composition in an aseptic container.
A23C 11/08 - Succédanés du lait, p. ex. compositions pour remplacer le lait dans le café au lait contenant au moins un composé d'origine non laitière comme source de matières grasses ou de protéines contenant des caséinates mais pas d'autres protéines ni matières grasses d'origine laitière
A23F 3/14 - Préparations à base de thé, p. ex. utilisant des additifs
A23F 5/14 - Utilisation d'additifs, p. ex. du lait ou du sucreEnrobage
A23L 29/00 - Aliments ou produits alimentaires contenant des additifsLeur préparation ou leur traitement
The present invention concerns a one-piece paper-moulded container made of cellulosic fibre and comprising: - a cup body, having an accommodating cavity with an opening at one end, the accommodating cavity being used to hold an edible substance, - an outer edge, arranged around an outer periphery of the opening of the paper-moulded cup body, and - a bend transition portion positioned between the cup body and the outer edge and connecting the two, which further comprises a paper-moulded protruding platform, having a greater thickness than the cup body, the fibre density of the protruding platform being comprised between 650 and 750 kg/m3, and the thickness of said protruding platform being comprised between 900 microns and 1.2 millimetres.
D21J 3/10 - Fabrication d'articles par pressage d'une pâte fibreuse humide ou de papier mâché, entre des moules de corps creux
D21J 7/00 - Fabrication d'articles creux à partir de suspensions de fibres ou de papier mâché, par dépôt de fibres dans ou sur un moule en treillis métallique
B65D 85/804 - Réceptacles ou emballages jetables dont le contenu est infusé ou dissous en restant dans l'emballage
The present invention relates to a method for making a one-piece paper-moulded container comprising: - providing a slurry suction mould comprising a slurry suction mould body with a recessed mould cavity and a paper-moulding cellulosic fibres slurry, - placing the slurry suction mould recessed cavity in the paper-moulding slurry and performing slurry suction, then - performing setting to obtain a paper-moulding blank having at least 10% water content; and - hot-pressing the paper-moulding blank in a mould cavity, to obtain the paper- moulded container.
D21J 3/10 - Fabrication d'articles par pressage d'une pâte fibreuse humide ou de papier mâché, entre des moules de corps creux
D21J 7/00 - Fabrication d'articles creux à partir de suspensions de fibres ou de papier mâché, par dépôt de fibres dans ou sur un moule en treillis métallique
29.
METHOD OF FORMING A CAPSULE, SYSTEM FOR FORMING A CAPSULE, PREFORM, AND CAPSULE
The present invention relates to a method of forming a capsule configured to house a food substance, comprising at least: providing at least one mold which comprises at least one molding surface; putting the mold at least partially in a slurry bath comprising a plurality of fibers such that the molding surface of the mold is at least partially submerged in the slurry bath; urging at least a portion of the fibers against at least a section of the molding surface of the mold to provide at least a portion of a preform of the capsule on the mold; removing the mold from the slurry bath; arranging at least one blocking element relative to the mold; putting the mold and the blocking element at least partially in the slurry bath such that the molding surface of the mold and the blocking element are at least partially submerged in the slurry bath; urging at least a portion of the fibers in the slurry bath against at least a section of the preform, wherein the blocking element substantially prevents fibers from accumulating at at least a first section of the preform while the blocking element allows fibers to accumulate at a second section of the preform. The present invention further relates to a system for forming a capsule, a preform, and a capsule.
D21J 3/10 - Fabrication d'articles par pressage d'une pâte fibreuse humide ou de papier mâché, entre des moules de corps creux
D21J 7/00 - Fabrication d'articles creux à partir de suspensions de fibres ou de papier mâché, par dépôt de fibres dans ou sur un moule en treillis métallique
A method for dispensing one or more frozen food products from a lockable top-opening freezer, wherein the freezer defines a volume accessible by a door of the freezer, the volume contains the one or more frozen food products, and the freezer comprises an electronically controlled lock configured to be controlled to lock and unlock the door thereby preventing and granting access to the volume and the one or more frozen food products, the method comprising the steps of: identifying the freezer with a user mobile device; communicating with the electronically controlled lock to unlock the door of the freezer; identifying on the user mobile device one or more frozen food products and initiating a payment process; and optionally communicating with the electronically controlled lock to lock the door of the freezer.
G06Q 20/18 - Architectures de paiement impliquant des terminaux en libre-service, des distributeurs automatiques, des bornes ou des terminaux multimédia
G07C 9/00 - Enregistrement de l’entrée ou de la sortie d'une entité isolée
31.
MULTILAYER METALLIZED PAPER-BASED PACKAGING MATERIAL
The present invention relates to a cellulosic substrate comprising or consisting of a cellulose graft copolymer comprising polypeptide branches. The present invention also relates to a packaging material comprising at least one paper layer comprising or consisting of a cellulose graft copolymer comprising polypeptide branches, in particular a multi-layer metallized paper-based packaging material.
D21H 19/12 - Couches sans pigments appliquées sous forme d'une solution utilisant de l'eau comme solvant unique, p. ex. en présence de composés acides ou alcalins
D21H 19/20 - Couches sans pigments appliquées sous une forme autre que la solution aqueuse définie dans le groupe comprenant des composés macromoléculaires obtenus par des réactions faisant intervenir uniquement des liaisons non saturées carbone-carbone
D21H 19/66 - Couches caractérisées par un effet visuel particulier, p. ex. avec des dessins ou texturées
D21H 19/72 - Papier couché caractérisé par le substrat de papier
32.
PAPER-MOULDED CONTAINER AND METHOD FOR MAKING SAME
The present invention relates to a one-piece paper-moulded container made of cellulosic fibre and comprising: - a cup body, having an accommodating cavity with an opening at one end, the accommodating cavity being used to hold an edible substance; - an outer edge, arranged around an outer periphery of the opening of the paper-moulded cup body, and - a bend transition portion positioned between the cup body and the outer edge, wherein the cup body has a greater thickness than the outer edge, wherein the fibre density in the bend transition portion is comprised between 750 and 1400 kg/m3, and wherein the thickness in the bend transition portion is comprised between 150 and 800 microns.
D21J 3/10 - Fabrication d'articles par pressage d'une pâte fibreuse humide ou de papier mâché, entre des moules de corps creux
D21J 7/00 - Fabrication d'articles creux à partir de suspensions de fibres ou de papier mâché, par dépôt de fibres dans ou sur un moule en treillis métallique
B65D 85/804 - Réceptacles ou emballages jetables dont le contenu est infusé ou dissous en restant dans l'emballage
A coffee bean roasting machine comprising: a roasting unit with a roasting chamber to roast a dose of coffee beans; a dosing unit, and; a coffee bean reservoir to contain multiple doses of coffee beans, wherein the dosing unit is arranged to extract a pre-portioned dose of coffee beans from the multiple doses of coffee beans of the reservoir and to transfer the pre-portioned dose to the roasting unit.
The present invention relates to a frozen food product coated with a coating, the coating comprising a compound selected from acacia gum, arabic gum, gellan gum, guar gum, locust bean gum, konjac gum, tara gum, a wax, an alginate, cellulose, whey protein isolate, corn zein, gluten, soy, caseinate, chitosan, carrageenan, gelatin, pullulan, modified starch, or combinations thereof.
A21D 15/02 - Amélioration de produits finis de boulangerie par refroidissement
A23L 7/109 - Types de pâtes alimentaires, p. ex. macaroni ou nouilles
A23L 7/196 - Produits dans lesquels la forme originale granulaire est maintenue, p. ex. riz précuit
A23L 19/12 - Produits à base de fruits ou de légumesLeur préparation ou leur traitement de tubercules ou d'autres racines contenant de l'amidon de pommes de terre
37.
PROCESS FOR PREPARING BOUILLON TABLET AND BOUILLON TABLET
A process for preparing a bouillon tablet, wherein the process comprises: mixing salt, oil and/or fat, and flavors to provide a bouillon ingredient composition; and pressing the bouillon ingredient composition into a tablet; characterized in that the bouillon ingredient composition is pressed into the shape of a biconvex tablet having an upper convex surface and a lower convex surface connected by a cylindrical band. A bouillon tablet comprising salt, oil and/or fat, and flavors, characterised in that the tablet is a biconvex tablet having an upper convex surface and a lower convex surface connected by a cylindrical band.
The invention concerns a beverage preparation machine and a pod containing a beverage ingredient, wherein a machine-readable code (34) storing preparation information is arranged on the surface of at least one of the enclosing walls, wherein the beverage preparation machine comprises: —an extraction device for extracting a beverage from the pod, and —a code reading system to read the code of the pod, and wherein the code reading system includes a code reader (9) and a positioning mechanism to move the pod and the code reader relative to each other: from a holding position, in which the pod is separated from a reading head (91) of the code reader, to a reading position, in which the code of the pod is in contact with the reading head, and wherein the beverage preparation machine comprises a pre-piercing arrangement (28) configured to pierce the pod before the code of the pod is read in the reading position.
A47J 31/44 - Éléments ou parties constitutives des appareils à préparer des boissons
A47J 31/06 - Filtres ou passoires pour appareils à café et à thé
A47J 31/36 - Appareils à préparer le café dans lesquels l'eau chaude passe sous pression à travers le filtre avec de l'eau chaude sous pression d'un liquide avec des moyens mécaniques pour produire la pression
39.
COMBINATION FOR USE IN BRAIN HEALTH AND INCREASING MENTAL PERFORMANCE
The present invention relates to compositions comprising taurine and at least one of B vitamins, in particular Vitamin B9, for increasing glutathione levels in the brain and/or improving mental performance such as motivational performance, and/or the ability to remained focus and sustain attention, and/or the feeling of energy and vigor.
A61K 31/519 - PyrimidinesPyrimidines hydrogénées, p. ex. triméthoprime condensées en ortho ou en péri avec des hétérocycles
A61K 31/145 - Amines, p. ex. amantadine ayant des atomes de soufre, p. ex. thiurames (N-C(S)-S-C(S)-N ou N-C(S)-S-S-C(S)-N)Sulfinylamines (-N=SO)Sulfonylamines (-N=SO2)
A food or beverage ingredient is produced from enzymatically hydrolysed cereal, by contacting a slurry of cereal bran with an enzyme composition including xylanase, alpha-amylase, beta-glucanase, cellulase and endoprotease. A beverage creamer composition may contain the food or beverage ingredient.
A23L 7/104 - Fermentation de céréales farineuses ou de produits de céréalesAdjonction d'enzymes ou de micro-organismes
A23C 11/10 - Succédanés du lait, p. ex. compositions pour remplacer le lait dans le café au lait contenant au moins un composé d'origine non laitière comme source de matières grasses ou de protéines contenant ou non du lactose mais pas d'autres composés d'origine laitière comme sources de matières grasses, d'hydrates de carbone ou de protéines
A bouillon tablet comprising salt, sweetener, oil and/or fat and flavors, characterized in that the bouillon tablet comprises an edible coating comprises a coating material selected from the group consisting of gelatine, gellan gum, waxes, pullulan, whey protein isolate, cellulose, alginates, corn zein, gluten, soy protein, caseinate, chitosan, pectin, carrageenan, xanthan gum, acacia (arabic) gum, agar, guar gum, modified starch, locust bean gum, konjac gum, and tara gum, or combinations thereof. The tablet may be a biconvex tablet having an upper convex surface (401, 501) and a lower convex surface (405, 505) connected by a cylindrical band (403, 503). The edible coating may comprise one or more herbs or spices.
A23L 27/20 - Épices, agents aromatiques ou condiments synthétiques
A23L 29/238 - Aliments ou produits alimentaires contenant des additifsLeur préparation ou leur traitement contenant des agents gélifiants ou épaississants d'origine végétale à partir de graines, p. ex. gomme de caroube ou gomme de guar
A23P 10/20 - AgglomérationGranulationMise en comprimés
A23P 10/28 - Mise en comprimésFabrication de produits alimentaires en barres par compression d’un mélange pulvérulent sec
A container for containing a precursor material for use with a machine for preparing a beverage and/or foodstuff or a precursor thereof, the container including a machine-readable code storing preparation information for use with a preparation process performed by said machine, the code comprising: a reference portion (R) to locate the code, and; a data portion (D) to store the preparation information, wherein the reference portion comprises reference units arranged to uniquely define a linear virtual reference line (r), wherein the data portion comprises data units which at least partially encode values of parameters of the preparation information as geometric distances (d) of the data units from a start position along each of a plurality of virtual encoding lines (E), wherein said plurality of encoding lines are circular and are arranged to intersect the reference line (r), and an innermost encoding line has a smaller radii than an outermost encoding line, wherein: 1) an outermost encoding line encodes two or more values of the same parameter, which are encoded in a sequence according to an order of use of the parameter, each of said values being encoded with a single data unit arrangeable at any continuous position from a start position; 2) an innermost encoding line encodes a value of a parameter, which is encoded as an average distance of two data units from a start position, and; 3) said innermost encoding line encodes binary information of the preparation information, which is encoded as an absence or presence of a unit at a predetermined position with respect to one of the units encoding the parameter on the innermost encoding line.
A47J 31/44 - Éléments ou parties constitutives des appareils à préparer des boissons
H04N 19/61 - Procédés ou dispositions pour le codage, le décodage, la compression ou la décompression de signaux vidéo numériques utilisant un codage par transformée combiné avec un codage prédictif
44.
METHODS RELATED TO BIOLOGICAL AGE USING METABOLITE BIOMARKERS
The present invention comprises a method for determining the biological age of an animal, wherein the method comprises determining the level of at least one biomarker in said animal, and wherein the at least 1 biomarker is selected from the biomarkers as listed in Table 1.
G01N 33/92 - Analyse chimique de matériau biologique, p. ex. de sang ou d'urineTest par des méthodes faisant intervenir la formation de liaisons biospécifiques par ligandsTest immunologique faisant intervenir des lipides, p. ex. le cholestérol
G01N 33/53 - Tests immunologiquesTests faisant intervenir la formation de liaisons biospécifiquesMatériaux à cet effet
G01N 33/68 - Analyse chimique de matériau biologique, p. ex. de sang ou d'urineTest par des méthodes faisant intervenir la formation de liaisons biospécifiques par ligandsTest immunologique faisant intervenir des protéines, peptides ou amino-acides
G16B 25/10 - Profilage de l’expression de gènes ou de protéinesEstimation ou normalisation de ratio d’expression
The present disclosure provides systems and methods for predicting the health state of cats, e.g., renal health. The method can include obtaining load data over time from interactions of a cat with a litter box, e.g., a smart litter box system, and using the load data in conjunction with a machine learning model with feature recognition of at least one feature based on the load data that indicates compromised health. The method can also include predicting the compromised renal health of the cat is with at least about 75% renal precision using at least a 0.5 probability threshold based on the feature recognition of the at least one feature.
G16H 50/20 - TIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicalesTIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour le diagnostic assisté par ordinateur, p. ex. basé sur des systèmes experts médicaux
The present invention relates to a capsule for a brewing device, the capsule having a side wall and, at opposing ends, an inflow end and an outflow end, and housing an ingredient compartment therebetween, and wherein the capsule comprises a permeable membrane located between the ingredient compartment and the outflow end, the permeable membrane affixed to a continuous perimeter of an internal face of the side wall.
C12M 3/02 - Appareillage pour la culture de tissus, de cellules humaines, animales ou végétales, ou de virus comportant des moyens fournissant des suspensions
C12M 3/06 - Appareillage pour la culture de tissus, de cellules humaines, animales ou végétales, ou de virus avec des moyens de filtration, d'ultrafiltration, d'osmose inverse ou de dialyse
C12M 1/06 - Appareillage pour l'enzymologie ou la microbiologie avec des moyens d'introduction de gaz avec agitateur, p. ex. avec agitateur à turbine
C12M 1/00 - Appareillage pour l'enzymologie ou la microbiologie
Described herein is a multilayer material for forming packaging, such as a beverage container, the material comprising a first paper-based layer, a polymeric layer on the first paper-based layer, an inorganic barrier layer on the polymeric layer, and a second paper-based layer, wherein the polymeric layer and the inorganic barrier layer are located in-between the first paper-based layer and the second paper-based layer. The use of the multilayer material for preparing packaging, packaging comprising the multilayer material, and a method of manufacturing the multilayer material is also described.
B32B 7/12 - Liaison entre couches utilisant des adhésifs interposés ou des matériaux interposés ayant des propriétés adhésives
B32B 15/08 - Produits stratifiés composés essentiellement de métal comprenant un métal comme seul composant ou comme composant principal d'une couche adjacente à une autre couche d'une substance spécifique de résine synthétique
B32B 15/082 - Produits stratifiés composés essentiellement de métal comprenant un métal comme seul composant ou comme composant principal d'une couche adjacente à une autre couche d'une substance spécifique de résine synthétique comprenant des résines vinyliquesProduits stratifiés composés essentiellement de métal comprenant un métal comme seul composant ou comme composant principal d'une couche adjacente à une autre couche d'une substance spécifique de résine synthétique comprenant des résines acryliques
B32B 15/085 - Produits stratifiés composés essentiellement de métal comprenant un métal comme seul composant ou comme composant principal d'une couche adjacente à une autre couche d'une substance spécifique de résine synthétique comprenant des polyoléfines
B32B 15/095 - Produits stratifiés composés essentiellement de métal comprenant un métal comme seul composant ou comme composant principal d'une couche adjacente à une autre couche d'une substance spécifique de résine synthétique comprenant des polyuréthanes
B32B 15/12 - Produits stratifiés composés essentiellement de métal comprenant un métal comme seul composant ou comme composant principal d'une couche adjacente à une autre couche d'une substance spécifique de papier ou de carton
B32B 15/20 - Produits stratifiés composés essentiellement de métal comportant de l'aluminium ou du cuivre
B32B 27/08 - Produits stratifiés composés essentiellement de résine synthétique comme seul composant ou composant principal d'une couche adjacente à une autre couche d'une substance spécifique d'une résine synthétique d'une sorte différente
B32B 27/10 - Produits stratifiés composés essentiellement de résine synthétique comme seul composant ou composant principal d'une couche adjacente à une autre couche d'une substance spécifique de papier ou de carton
B32B 27/30 - Produits stratifiés composés essentiellement de résine synthétique comprenant une résine vinyliqueProduits stratifiés composés essentiellement de résine synthétique comprenant une résine acrylique
B32B 27/32 - Produits stratifiés composés essentiellement de résine synthétique comprenant des polyoléfines
B32B 27/40 - Produits stratifiés composés essentiellement de résine synthétique comprenant des polyuréthanes
B32B 29/00 - Produits stratifiés composés essentiellement de papier ou de carton
A multi-stage system for food topping assembly is provided. In certain embodiments, the system comprises a material transport tool configured to transport topping elements; a coarse topping patterning tool configured to arrange topping elements into a coarse pattern on the material transport tool; and a precision topping patterning tool configured to finalise the arrangement of topping elements on the material transport tool into a target pattern.
A21C 9/04 - Appareils à épandre des matières granuleuses sur la surface des pièces ou des feuilles de pâte, ou pour enrober ou recouvrir celles-ci de ces matières
A21C 9/08 - Appareils à déposer, aligner et transporter, pour la manipulation de pièces, p. ex. les feuilles de pâte
A21C 15/00 - Appareils pour la manutention des produits cuits
50.
METHODS RELATED TO BIOLOGICAL AGE USING METABOLITE BIOMARKERS
The present invention comprises a method for determining the biological age of an animal, wherein the method comprises determining the level of at least one biomarker in said animal, and wherein the at least 1 biomarker is selected from the biomarkers as listed in Table 1.
G01N 33/68 - Analyse chimique de matériau biologique, p. ex. de sang ou d'urineTest par des méthodes faisant intervenir la formation de liaisons biospécifiques par ligandsTest immunologique faisant intervenir des protéines, peptides ou amino-acides
Methods of predicting mobility of dog movement, under the control of at least one processor, can include collecting movement sensor data from a wearable monitoring device positioned on a dog, wherein the wearable monitoring device includes an accelerometer and a gyroscope (each capable of collecting three axial signals), a processor, and a memory storing instructions that, when executed by the processor, accumulates the movement sensor data in time windows. The method further includes classifying movement behavior as a binary of walk or trot within at least a plurality of the time windows based on the movement sensor data collected from multiple axes of the accelerometer and multiple axes of the gyroscope, and predicting mobility of dog movement based on the movement behaviors as applied to a trained artificial intelligence mobility model. Predicting the mobility of the dog movement can include predicting a binary of healthy mobility or compromised mobility.
G16H 20/00 - TIC spécialement adaptées aux thérapies ou aux plans d’amélioration de la santé, p. ex. pour manier les prescriptions, orienter la thérapie ou surveiller l’observance par les patients
Sparkling water, products for making sparkling water,
preparations for making beverages, non-alcoholic fruit
extracts, non-alcoholic beverages containing fruit juices,
fruit juices, beverages made with fruit syrups, lemonades,
lithia water, mineral water (beverages), products for making
mineral water, orgeat, seltzer water, soft drinks, table
water.
05 - Produits pharmaceutiques, vétérinaires et hygièniques
29 - Viande, produits laitiers et aliments préparés ou conservés
Produits et services
Food for babies; lacteal flour for babies; powdered milk for
babies; food and food substances for babies. Milk and dairy products; Powdered milk; milk-based beverages
and preparations.
55.
COMPOSITIONS AND METHODS USING A COMBINATION OF OLEUROPEIN AND TAURINE
Composition comprising a combination of oleuropein or metabolite thereof and taurine or functional derivative thereof are provided. The composition may be an oral nutritional composition, for example a nutritional supplement, an oral nutritional supplement, a food product, a food for special medical purpose (FSMP). The composition can be administered to an individual in need thereof for improving a physiological state linked to metabolic fatigue in one or more cells, (ii) increasing mitochondrial energy and mitochondrial calcium uptake in one or more cells, and (iii) increasing antioxidant capacity, reducing oxidative stress and/or enhancing mitochondrial function, (iv) treating or preventing a calcium deficiency/depletion disorder in an individual. Additionally or alternatively, the method can treat or prevent a mitochondria-related disease or a condition associated with altered mitochondrial function in an individual in need thereof or at risk thereof.
The present invention relates to compositions for use in the prevention of accelerated growth in an offspring, said composition comprising myo-inositol, a combination of Lactobacillus and Bifidobacterium and at least one vitamin selected from the group consisting of vitamin B2, vitamin B6, vitamin B12, vitamin D and mixtures thereof, and wherein the composition is administered to the mother of said offspring during preconception, and/or pregnancy and/or during lactation periods. The present invention further relates to a kit of part for preventing accelerated growth in an offspring.
The present invention provides methods for inducing a formula-fed infant's gut microbiome trajectory to converge with that of a reference gut microbiome trajectory obtained from human milk-fed infants, the methods comprising administering an effective amount of a mixture of human milk oligosaccharides (HMOs) to the formula-fed infant. The present invention also provides methods for determining the gut maturation status of a formula-fed infant, the methods comprising providing a reference gut microbiome trajectory obtained from human milk-fed infants.
The present invention comprises a method for determining the biological age of an animal, wherein the method comprises determining the level of at least one biomarker in said animal, and wherein the at least 1 biomarker is selected from the biomarkers as listed in Table 1.
G01N 33/92 - Analyse chimique de matériau biologique, p. ex. de sang ou d'urineTest par des méthodes faisant intervenir la formation de liaisons biospécifiques par ligandsTest immunologique faisant intervenir des lipides, p. ex. le cholestérol
59.
COMPOSITIONS AND NUTRITIONAL PRODUCTS WITH IMPROVED EMULSION STABILITY
The present invention relates to a method of preparing a protein composition, comprising enzymatic modification of milk lecithin using phospholipase. This protein composition is then included in nutritional products to increase emulsion quality and heat stability of the final nutritional products.
A preform for forming a bottle for gaseous beverage includes a multilayered wall obtained by injection in a mould from an injecting point located at a central bottom end of the preform. The multilayered wall includes an inner layer, an outer layer and a gas barrier layer sandwiched between the inner and outer layer. The gas barrier layer advantageously extends along the entire preform multilayered wall except for a bottom ending portion. This bottom ending portion free of barrier layer is a central part of a base-forming portion delimited by a solid angle (α) between 5° to 80°, and the apex of this solid angle is the centre of a semi-spherical lower segment of the base-forming portion. A bottle obtained by blow-moulding such a preform has a bottom ending portion free of barrier layer within a solid angle between 5° and 50°.
The present invention comprises a method for determining the biological age of an animal, wherein the method comprises determining the level of at least one biomarker in said animal, and wherein the at least 1 biomarker is selected from the biomarkers as listed in Table 1.
G01N 33/68 - Analyse chimique de matériau biologique, p. ex. de sang ou d'urineTest par des méthodes faisant intervenir la formation de liaisons biospécifiques par ligandsTest immunologique faisant intervenir des protéines, peptides ou amino-acides
G01N 33/74 - Analyse chimique de matériau biologique, p. ex. de sang ou d'urineTest par des méthodes faisant intervenir la formation de liaisons biospécifiques par ligandsTest immunologique faisant intervenir des hormones
The present disclosure provides systems and methods for predicting the health state of cats, e.g., renal health. The method can include obtaining load data over time from interactions of a cat with a litter box, e.g., a smart litter box system, and using the load data in conjunction with a machine learning model with feature recognition of at least one feature based on the load data that indicates compromised health. The method can also include predicting the compromised renal health of the cat is with at least about 75% renal precision using at least a 0.5 probability threshold based on the feature recognition of the at least one feature.
G16H 50/20 - TIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicalesTIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour le diagnostic assisté par ordinateur, p. ex. basé sur des systèmes experts médicaux
G16H 50/30 - TIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicalesTIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour le calcul des indices de santéTIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicalesTIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour l’évaluation des risques pour la santé d’une personne
A61B 5/00 - Mesure servant à établir un diagnostic Identification des individus
G16H 40/63 - TIC spécialement adaptées à la gestion ou à l’administration de ressources ou d’établissements de santéTIC spécialement adaptées à la gestion ou au fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement local
G16H 50/70 - TIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicalesTIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour extraire des données médicales, p. ex. pour analyser les cas antérieurs d’autres patients
The present invention comprises a method for determining the biological age of an animal, wherein the method comprises determining the level of at least one biomarker in said animal, and wherein the at least 1 biomarker is selected from the biomarkers as listed in Table 1.
G01N 33/68 - Analyse chimique de matériau biologique, p. ex. de sang ou d'urineTest par des méthodes faisant intervenir la formation de liaisons biospécifiques par ligandsTest immunologique faisant intervenir des protéines, peptides ou amino-acides
69.
METHODS RELATED TO BIOLOGICAL AGE USING PROTEIN BIOMARKERS
The present invention comprises a method for determining the biological age of an animal, wherein the method comprises determining the level of at least one biomarker in said animal, wherein at least 1 biomarker is selected from the biomarkers as listed in Table 1.
G01N 33/68 - Analyse chimique de matériau biologique, p. ex. de sang ou d'urineTest par des méthodes faisant intervenir la formation de liaisons biospécifiques par ligandsTest immunologique faisant intervenir des protéines, peptides ou amino-acides
Methods of predicting mobility of dog movement, under the control of at least one processor, can include collecting movement sensor data from a wearable monitoring device positioned on a dog, wherein the wearable monitoring device includes an accelerometer and a gyroscope (each capable of collecting three axial signals), a processor, and a memory storing instructions that, when executed by the processor, accumulates the movement sensor data in time windows. The method further includes classifying movement behavior as a binary of walk or trot within at least a plurality of the time windows based on the movement sensor data collected from multiple axes of the accelerometer and multiple axes of the gyroscope, and predicting mobility of dog movement based on the movement behaviors as applied to a trained artificial intelligence mobility model. Predicting the mobility of the dog movement can include predicting a binary of healthy mobility or compromised mobility.
A composition contains one or more aromatic amino acids and optionally vitamin B6. The composition may be an oral nutritional composition, for example a nutritional supplement, an oral nutritional supplement, a food product, a food for special medical purpose (FSMP). The composition can be in a form of a powder, a powdered stick, a capsule or a solution. The composition can be administered to an individual in need thereof orally or intravenously for preventing and/or treating sarcopenia, a loss of and/or improving skeletal muscle mass, lean muscle mass, skeletal muscle strength and/or skeletal muscle function.
The present invention relates to the treatment or prevention of conditions linked to reduced muscle mass or reduced muscle protein synthesis rate. A subject matter of the invention is a composition comprising complexes of whey protein micelles and pectin for use in the treatment or prevention of a condition selected from the group consisting of sarcopenia, muscle atrophy and negative nitrogen balance. Further aspects of the invention relate to the non-therapeutic use of a composition comprising complexes of whey protein micelles and pectin and a food composition.
The present invention relates to bone health and in particular to use of a composition comprising a combination of taurine and vitamin B12 for prevention or treatment of bone disorders or maintenance of bone health. The present invention also relates to compositions and methods for enhancing bone quality, bone growth and/or bone strength.
The present invention relates to use of a composition comprising an effective amount of a combination of taurine and vitamin B12 for maintenance of joint health or prevention or treatment of joint disorders in an individual. In particular, the invention relates to a composition comprising an effective amount of a combination of taurine and vitamin B12 for use to prevent or treat cartilage degeneration in an individual.
The present invention relates to bone health and in particular to use of a composition comprising a combination of taurine and vitamin B6 for prevention or treatment of bone disorders or maintenance of bone health. The present invention also relates to compositions and methods for enhancing bone quality, bone growth and/or bone strength.
The present invention relates to compositions comprising at least one source of polyamine precursors for use in promoting neurodevelopment in a young individual.
The present invention relates to compositions comprising at least one source of polyamines or their metabolites for use in promoting neurodevelopment in a young individual.
The present invention comprises a method for determining the biological age of an animal, wherein the method comprises determining the level of at least one biomarker in said animal, wherein at least 1 biomarker is selected from the biomarkers as listed in Table 1.
G01N 33/68 - Analyse chimique de matériau biologique, p. ex. de sang ou d'urineTest par des méthodes faisant intervenir la formation de liaisons biospécifiques par ligandsTest immunologique faisant intervenir des protéines, peptides ou amino-acides
81.
FIBER BLENDS PROVIDING HEALTH BENEFITS IN A FELINE
Compositions and methods from providing a health benefit to a feline include the use of a prebiotic fiber blend comprising psyllium, short chain fructo-oligosaccharides (scFOS), aleurone, and barley.
A23K 10/30 - Produits alimentaires pour animaux à base de matières d’origine végétale, p. ex. de racines, de graines ou de foinProduits alimentaires pour animaux à base de matières d’origine fongique, p. ex. de champignons
A23K 50/40 - Produits alimentaires spécialement conçus pour des animaux spécifiques pour les animaux carnivores, p. ex. pour les chats ou les chiens
A23L 33/21 - Adjonction de substances essentiellement non digestibles, p. ex. de fibres diététiques
A61P 13/12 - Médicaments pour le traitement des troubles du système urinaire des reins
Compositions and methods from providing a health benefit to a feline include the use of a prebiotic fiber blend comprising pumpkin, chicory, beet pulp, citrus, and barley.
A23K 10/30 - Produits alimentaires pour animaux à base de matières d’origine végétale, p. ex. de racines, de graines ou de foinProduits alimentaires pour animaux à base de matières d’origine fongique, p. ex. de champignons
A23K 50/40 - Produits alimentaires spécialement conçus pour des animaux spécifiques pour les animaux carnivores, p. ex. pour les chats ou les chiens
A61K 36/21 - Amaranthaceae (famille de l'amaranthe), p. ex. amaranthe réfléchie ou amarantine globuleuse
A61K 36/28 - Asteraceae ou Compositae (famille de l'aster ou du tournesol), p. ex. camomille, chrysanthème matricaire, achillée ou echinacée
A61K 36/752 - Citrus, p. ex. citron vert, orange ou citron
Compositions and methods from providing a health benefit to a feline include the use of a prebiotic fiber blend comprising psyllium, short chain fructo-oligosaccharides (scFOS), aleurone, and barley.
A23K 10/30 - Produits alimentaires pour animaux à base de matières d’origine végétale, p. ex. de racines, de graines ou de foinProduits alimentaires pour animaux à base de matières d’origine fongique, p. ex. de champignons
A61P 1/00 - Médicaments pour le traitement des troubles du tractus alimentaire ou de l'appareil digestif
A61P 1/16 - Médicaments pour le traitement des troubles du tractus alimentaire ou de l'appareil digestif des troubles de la vésicule biliaire ou du foie, p. ex. protecteurs hépatiques, cholagogues, cholélitholytiques
85.
D-BHB (D-BETA-HYDROXYBUTYRATE) FOR TREATMENT OF MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY (MADD)
The present invention relates to the use of D-beta-hydroxybutyrate (D-BHB) in the treatment or dietary management of multiple acyl-CoA dehydrogenase deficiency (MADD), for example, in the prevention and/or amelioration of one or more symptoms associated with MADD. Further provided herein are methods of treatment or dietary managements of MADD in a subject in need, comprising administering to said subject a composition comprising D-BHB as the active ingredient.
SOCPRA SCIENCES SANTE ET HUMAINES, S.E.C. (Canada)
Inventeur(s)
Cuenoud, Bernard
Cunnane, Stephen Cosgrave
Abrégé
Methods improve cognitive functioning, for example, at least one of episodic memory, executive function, or language skills; support memory and/or recall; provide energy and/or ketones to the brain; and/or prevent and/or treat mild cognitive impairment (MCI) in an individual. A composition contains medium chain triglycerides (MCTs) and can be administered to the individual in a daily dosage providing from about 15 g to about 45 g MCTs. The MCTs can include from about 51 wt % to about 90 wt % of octanoic acid. The daily dose can be provided in at least two servings, for example, 2 or 3 servings. Each serving can provide about 15 g MCTs and can include octanoic acid and decanoic acid in a weight ratio of, for example, about 60:about 40. The individual can be 65 years or older and/or have mild cognitive impairment (MCI).
A61K 31/23 - Esters, p. ex. nitroglycérine, sélénocyanates d'acides carboxyliques d'acides acycliques, p. ex. pravastatine d'acides ayant un groupe carboxyle lié à une chaîne d'au moins sept atomes de carbone
A61P 25/28 - Médicaments pour le traitement des troubles du système nerveux des troubles dégénératifs du système nerveux central, p. ex. agents nootropes, activateurs de la cognition, médicaments pour traiter la maladie d'Alzheimer ou d'autres formes de démence
Ready to drink low sugar flavored dairy beverages are provided, and methods for making such beverages are also provided. The beverage can include a dairy component, a flavor component, and a stabilizing system comprising a first stabilizing component and a second stabilizing component. The flavor component can be at least one of a cocoa component or a fruit flavoring component. The first stabilizing component is microcrystalline cellulose, carboxymethyl cellulose and further comprising carrageenans, and the second stabilizing component is at least one of gellan or a modified starch. Sugar can be present in the beverage in an amount up to about 4.5% of the beverage. The beverage can be aseptic and stable in a homogenous state for at least three months in ambient storage and preferably at least six months in ambient storage.
A23C 9/154 - Préparations à base de laitLait en poudre ou préparations à base de lait en poudre comportant des additifs contenant des substances épaississantes, des œufs ou des préparations à base de céréalesLait gélifié
The present invention relates to feed additives, specifically a combination of feed additives that can be used to both reduce cattle methane emissions, and also increase animal productivity. This increase in productivity may be achieved through a reduction in both enteric methane emissions and also a reduction in the accumulation of hydrogen in the rumen.
A23K 10/18 - Ajout de micro-organismes ou de leurs produits d’extraction, p. ex. de protéines provenant d’organismes unicellulaires, à des compositions de produits alimentaires de micro-organismes vivants
A23K 20/105 - Composés aliphatiques ou alicycliques
A23K 50/10 - Produits alimentaires spécialement conçus pour des animaux spécifiques pour les ruminants
89.
BEVERAGE PREPARATION WITH COMPACT CONDITIONING CHAMBER
A machine (1) has: a rotatable ingredient handling system (10,20) to hold and rotate a flavouring ingredient (5a) and water for centrifugation about a processing axis (30') in a processing cavity (5) so as to form a beverage (4). The machine (1) includes a beverage conditioner (50) in fluid communication with and downstream of the processing cavity (5). The conditioner (50) has a conditioning cavity (51) in which the beverage (4) supplied from the processing cavity (5) is conditioned. The conditioning cavity (51) is delimited by a first conditioning surface (52,52a) and a second conditioning surface (53,53a) which surfaces (52,52a,53,53a) face each other and are movable one relative to and over the other. At least one surface (52,52a) of the first and second conditioning surfaces (52,52a,53,53a) is provided with a beverage impeller (52',52'') comprising: one or more protrusions (52'); and/or one or more recesses (52'').
The present invention relates to use of a composition comprising an effective amount of a combination of taurine and vitamin B9 for maintenance of joint health or prevention or treatment of joint disorders in an individual. In particular, the invention relates to a composition comprising an effective amount of a combination of taurine and vitamin B9 for use to prevent or treat cartilage degeneration in an individual.
The present invention relates to use of a composition comprising an effective amount of a combination of taurine and vitamin B6 for maintenance of joint health or prevention or treatment of joint disorders in an individual. In particular, the invention relates to a composition comprising an effective amount of a combination of taurine and vitamin B6 for use to prevent or treat cartilage degeneration in an individual.
The present invention relates to bone health and in particular to use of a composition comprising a combination of taurine and vitamin B9 for prevention or treatment of bone disorders or maintenance of bone health. The present invention also relates to compositions and methods for enhancing bone quality, bone growth and/or bone strength.
The present invention comprises a method for determining the biological age of an animal, wherein the method comprises determining the level of at least one biomarker in said animal, and wherein the at least 1 biomarker is selected from the biomarkers as listed in Table 1.
G01N 33/68 - Analyse chimique de matériau biologique, p. ex. de sang ou d'urineTest par des méthodes faisant intervenir la formation de liaisons biospécifiques par ligandsTest immunologique faisant intervenir des protéines, peptides ou amino-acides
94.
FIBER BLENDS FOR PROVIDING HEALTH BENEFITS IN A FELINE
Compositions and methods from providing a health benefit to a feline include the use of a prebiotic fiber blend comprising pumpkin, chicory, beet pulp, citrus, and barley.
A23K 10/30 - Produits alimentaires pour animaux à base de matières d’origine végétale, p. ex. de racines, de graines ou de foinProduits alimentaires pour animaux à base de matières d’origine fongique, p. ex. de champignons
A23K 50/40 - Produits alimentaires spécialement conçus pour des animaux spécifiques pour les animaux carnivores, p. ex. pour les chats ou les chiens
A23L 33/21 - Adjonction de substances essentiellement non digestibles, p. ex. de fibres diététiques
A61P 13/12 - Médicaments pour le traitement des troubles du système urinaire des reins
The invention relates to a reduced dairy chocolate product, preferably a vegan chocolate product composition comprising a dried emulsion of a plant protein.
A23G 1/44 - Produits à base de cacao, p. ex. chocolatLeurs succédanés caractérisés par la composition contenant des peptides ou des protéines
A23C 11/10 - Succédanés du lait, p. ex. compositions pour remplacer le lait dans le café au lait contenant au moins un composé d'origine non laitière comme source de matières grasses ou de protéines contenant ou non du lactose mais pas d'autres composés d'origine laitière comme sources de matières grasses, d'hydrates de carbone ou de protéines
A23G 1/36 - Produits à base de cacao, p. ex. chocolatLeurs succédanés caractérisés par la composition caractérisés par les matières grasses utilisées
A23G 1/40 - Produits à base de cacao, p. ex. chocolatLeurs succédanés caractérisés par la composition caractérisés par les hydrates de carbone utilisés, p. ex. des polysaccharides
A23G 1/48 - Produits à base de cacao, p. ex. chocolatLeurs succédanés caractérisés par la composition contenant des végétaux ou des parties de ceux-ci, p. ex. des fruits, des graines, des extraits
The present disclosure relates to systems, methods, and program applications for identifying separation-related problems in a pet. The methods, for example, can include identifying the presence or absence of multiple behavioral signs exhibited by a pet where each of the multiple behavioral signs are given a sign score based on binary annotations representing either the presence or the absence of each of the behavioral signs, and grouping subsets of the multiple behavioral signs into one of multiple principal component behavioral groupings using the binary annotations to generate principal component scores for each of the multiple principal component behavioral groupings. Methods can also include using one or more machine-learning algorithms under the control of at least one processor for accessing and correlating the principal component scores for each of the multiple principal component behavioral groupings with a population cluster associated with a type of separation-related problem.
